DMAC
DiaMedica Therapeutics Inc.NASDAQHealthcare$6.48+0.93%ClosedMarket Cap: $337.5M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
5.54
P/S
0.00
EV/EBITDA
-9.59
DCF Value
$0.30
FCF Yield
-8.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-77.6%
ROA
-53.4%
ROIC
-61.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-9.2M | $-8.7M | $-0.17 | — |
| FY 2025 | $0.00 | NaN% | $-34.4M | $-32.8M | $-0.70 | — |
| Q3 2025 | $0.00 | -Infinity% | $-9.0M | $-8.6M | $-0.17 | — |
| Q2 2025 | $0.00 | NaN% | $-8.0M | $-7.7M | $-0.18 | — |
| Q1 2025 | $0.00 | NaN% | $-8.1M | $-7.7M | $-0.18 | — |
| Q4 2024 | $0.00 | -Infinity% | $-8.4M | $-7.9M | $-0.18 | — |
| FY 2024 | $0.00 | NaN% | $-26.7M | $-24.4M | $-0.60 | — |
| Q3 2024 | $0.00 | NaN% | $-6.9M | $-6.3M | $-0.15 | — |
| Q2 2024 | $0.00 | NaN% | $-5.6M | $-5.1M | $-0.13 | — |
| Q1 2024 | $0.00 | NaN% | $-5.7M | $-5.2M | $-0.14 | — |
| Q4 2023 | $0.00 | -Infinity% | $-5.8M | $-5.2M | $-0.14 | — |
| FY 2023 | $0.00 | NaN% | $-21.3M | $-19.4M | $-0.60 | — |